Medication-Assisted Treatment (MAT) on Long Island

What Is Medication-Assisted Treatment?

MAT uses medications like buprenorphine (Suboxone, Sublocade, Brixadi), naltrexone (Vivitrol), and methadone to stabilize brain chemistry, block the effects of opioids or alcohol, and relieve cravings — while counseling and support address the reasons behind the addiction. It is not "replacing one drug with another": these medications, taken as prescribed, don't produce a high. They give people the stability to work, parent, and rebuild. Federal agencies including SAMHSA and NIDA recognize MAT as the standard of care for opioid use disorder.

Comparing MAT Medications: Suboxone vs. Sublocade vs. Brixadi vs. Vivitrol vs. Methadone

The right medication depends on your substance history, how quickly you need to start, whether daily dosing fits your life, and what your insurance covers. Here's how the five options compare:

Related Treatment Options

MAT is not one-size-fits-all. Depending on your substance use history, schedule, and insurance, one of these nearby paths may be a better fit.

Find MAT Prescribers Near You on Long Island

If you've been searching for doctors that prescribe Suboxone near you or "Vivitrol providers near me," you've probably discovered the problem: directories are outdated, half the numbers don't answer, and the ones that do have month-long waits or don't take your insurance. That's the gap we close. We're not a clinic — we're navigators. We maintain current relationships with MAT prescribers across Long Island and match you based on medication, insurance, location, and how fast you need to start.

How matching works

1. 1
   Call or message us

   Tell us what you're using, what medication you're interested in (or let us walk you through the options), and your insurance.

2. 2
   We verify and match

   We confirm your coverage and identify prescribers with real availability — including same-week Suboxone inductions and clinics administering Sublocade, Brixadi, and Vivitrol.

3. 3
   You start treatment

   We coordinate the intake so you show up to a confirmed appointment, not a waitlist.

Is MAT Covered by Insurance in New York?

Almost always — and New York law is on your side. New York requires state-regulated commercial plans to cover medications for opioid use disorder without prior authorization for at least one formulary version of buprenorphine and for injectable naltrexone. NY Medicaid covers all FDA-approved MAT medications under a single statewide formulary, also without prior authorization. Where it gets complicated: Medicare splits coverage (office-administered injectables like Sublocade, Brixadi, and Vivitrol typically bill under Part B; take-home Suboxone films go through Part D), and self-funded employer plans regulated under federal ERISA law aren't bound by New York's mandates — coverage varies by plan.

You don't need to figure out which category your plan falls into — that's part of what we do. We verify MAT benefits before matching you with a prescriber, so there are no surprise denials at the pharmacy counter.

How Much Does MAT Cost on Long Island?

With insurance, most people pay a copay per visit plus a prescription copay — often $0–$50/month for Suboxone under commercial plans and $0 under Medicaid. Without insurance, approximate cash ranges on Long Island are below. Manufacturer copay assistance (inSupport for Sublocade, Brixadi Copay Assistance, Vivitrol Co-pay Savings) can reduce out-of-pocket costs to as little as $0–$10 for eligible commercially insured patients — we help you enroll as part of placement.

• Suboxone (generic bup/nx film)
  Cash: ~$60–$200/mo
  Insured: $0–$50/mo copay typical
• Prescriber office visit
  Cash: ~$150–$300
  Insured: Standard specialist copay
• Sublocade (monthly)
  Cash: ~$1,900–$2,000/injection list
  Insured: $0–$10 with inSupport copay assistance
• Brixadi (weekly/monthly)
  Cash: ~$1,900–$2,000/monthly-equivalent
  Insured: $0–$10 with Brixadi Copay Assistance
• Vivitrol (monthly)
  Cash: ~$1,500–$1,700/injection
  Insured: $0–$5 with Vivitrol Co-pay Savings

How Effective Is MAT Compared to Detox Alone?

This is the most important question on this page, and the evidence is unambiguous. Detox alone — getting through withdrawal without ongoing medication — has high relapse rates for opioid use disorder, and the period right after detox is the highest-risk window for fatal overdose because tolerance drops while cravings don't — a risk especially acute with fentanyl and heroin. Treatment with buprenorphine or methadone is associated with roughly a 50% reduction in overdose death and all-cause mortality compared to no medication, according to research cited by the National Institute on Drug Abuse. People on MAT stay in treatment longer, use illicit opioids less, and are more likely to keep jobs and custody of their children. SAMHSA's TIP 63 guidance is blunt about it: medication is the standard of care for opioid use disorder, and withholding it isn't a more "pure" form of recovery — it's a riskier one.

MAT works best when paired with structured care. Many people combine medication with intensive outpatient therapy, and those with more severe use histories often start in inpatient rehab before stepping down to ongoing MAT.

Authority sources: NIDA — Medications for Opioid Use Disorder · SAMHSA TIP 63.

Is MAT Safe During Pregnancy?

Yes — and it's strongly recommended over detox. For pregnant women with opioid use disorder, buprenorphine or methadone is the standard of care endorsed by ACOG and SAMHSA. Attempting withdrawal during pregnancy carries risks of relapse and overdose that endanger both mother and baby, while stable MAT is associated with better prenatal care engagement and healthier birth outcomes. Newborns may experience treatable neonatal abstinence syndrome, which hospitals on Long Island manage routinely — it is not a reason to avoid treatment. Vivitrol is generally not started during pregnancy. If you're pregnant and using opioids, this is a same-day placement priority for us: call and we'll connect you with prescribers experienced in perinatal MAT.

Frequently Asked Questions About MAT